Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Mesoblast Ltd (MESO)
NASDAQ:MESO
Mesoblast (MESO) Stock Price & Analysis
669 Followers
MESO Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.61 - $10.24
Previous Close$8.05
Volume139.51K
Average Volume (3M)218.28K
Market Cap
$919.42M
Enterprise Value$964.40M
Total Cash (Recent Filing)$71.51M
Total Debt (Recent Filing)$116.50M
Price to Earnings (P/E)―
Beta1.38
Next Earnings
Aug 28, 2024EPS Estimate
-$0.3Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.06
Shares Outstanding101,534,224
10 Day Avg. Volume111,798
30 Day Avg. Volume218,278
Standard Deviation0.35
R-Squared0.26
Alpha-0.00045
Financial Highlights & Ratios
Price to Book (P/B)-9.45
Price to Sales (P/S)94.89
Price to Cash Flow (P/CF)-10.90
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue170.78
Enterprise Value/Gross Profit128.57
Enterprise Value/Ebitda-21.02
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Mesoblast News
PremiumCompany Announcements
Mesoblast Seeks FDA Nod for Pediatric GVHD Treatment
PremiumCompany Announcements
Mesoblast to Seek FDA Approval for Ryoncil®
PremiumCompany Announcements
Mesoblast Eyes FDA Approval and Extends Patent Portfolio
PremiumCompany Announcements
Mesoblast Director Boosts Stake with Market PurchaseOwnership Overview
0.00%
Insiders
<0.01% Mutual Funds
0.05% Other Institutional Investors
99.94% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
MESO FAQ
What was Mesoblast Ltd’s price range in the past 12 months?
Mesoblast Ltd lowest stock price was $1.61 and its highest was $10.24 in the past 12 months.
What is Mesoblast Ltd’s market cap?
Currently, no data Available
When is Mesoblast Ltd’s upcoming earnings report date?
Mesoblast Ltd’s upcoming earnings report date is Aug 28, 2024 which is in 43 days.
How were Mesoblast Ltd’s earnings last quarter?
Currently, no data Available
Is Mesoblast Ltd overvalued?
According to Wall Street analysts Mesoblast Ltd’s price is currently Overvalued.
Does Mesoblast Ltd pay dividends?
Mesoblast Ltd does not currently pay dividends.
What is Mesoblast Ltd’s EPS estimate?
Mesoblast Ltd’s EPS estimate is -$0.3.
How many shares outstanding does Mesoblast Ltd have?
Mesoblast Ltd has 114,124,120 shares outstanding.
What happened to Mesoblast Ltd’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Mesoblast Ltd?
Currently, no hedge funds are holding shares in MESO
---
Mesoblast Stock Smart Score
Company Description
Mesoblast Ltd
Mesoblast Ltd. is a biopharmaceutical company, which engages in the research, development, and market of mesenchymal lineage adult stem cell technology platform. Its medicines target the cardiovascular diseases, spine orthopedic disorders, oncology and hematology, immune-mediated, and inflammatory diseases. The company was founded by Itescu Silviu on June 8, 2004 and is headquartered in Melbourne, Australia.
---
MESO Company Deck
---
MESO Earnings Call
Q2 2024
0:00 / 0:00
---
MESO Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Sarepta Therapeutics
―
Crispr Therapeutics AG
―
Editas Medicine
―
Voyager Therapeutics
―
Best Analysts Covering MESO
1 Year
1 Year Success Rate
2/5 ratings generated profit
1 Year Average Return
-5.78%
reiterated a buy rating 11 months ago
Copying Louise Chen's trades and holding each position for 1 Year would result in 40.00% of your transactions generating a profit, with an average return of -5.78% per trade.
---